drugset / Trial / NCT06174766
A Study to Evaluate Efficacy and Safety of HGP2102 in Essential Hypertension Patients
RandomizedParallel-groupDouble-blindTreatment
Summary
A Multicenter, Randomized, Double-blind, Phase 3 Study to Evaluate the Efficacy and Safety of HGP2102 in patients with Essential Hypertension
Timeline
- Start
- 2024-05-10
- Primary completion
- 2026-01-08
- Completion
- 2026-01-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HGP2102-1 | Unknown | — | Oral |
| Subject | HGP2102-2 | Unknown | — | Oral |
| Comparator | RLD2209-1 | Unknown | — | Oral |
| Comparator | RLD2209-2 | Unknown | — | Oral |